Variables | OR(95% CI) | P value | Variables | OR(95% CI) | P value |
---|---|---|---|---|---|
Age(years) | 1.026(1.01-1.05) | 0.01 | Hepatopulmonary Syndrome | Â | |
Gender | Â | No | 1.0 | 0.19 | |
  Female | 1.0 | 0.34 | Yes | 1.62(0.80-3.29) |  |
  Male | 1.26(0.77-2.05) |  | Total Bilirubin(mg/dl) |  | |
BMI (Kg/m2) | Â | <2 | 1.0 | 0.48 | |
  18-22.9 | 1.0 | 0.24 | 2-3 | 0.93(0.51-1.67) |  |
  <18 | 2.08(0.90-4.77) |  | >3 | 1.29(0.79-2.09) |  |
  23-24.9 | 1.34(0.74-2.43) |  | Albumin(mg/dl) |  | |
  ≥25 | 0.98(0.56-1.69) |  | >3.5 | 1.0 | 0.73 |
Diabetes Mellitus | Â | 2.8-3.5 | 0.73(0.32-1.62) | Â | |
  No | 1.0 | 0.02 | <2.8 | 0.74(0.35-1.56) |  |
  Yes | 1.64(1.07-2.53) |  | ALT (IU/ml) |  | |
Hypertension | Â | Normal | 1.0 | 0.19 | |
  No | 1.0 | 0.11 | Elevated | 0.58(0.37-0.91) |  |
  Yes | 1.42(0.92-2.21) |  | Prothrombin time(second) |  | |
Dyslipidemia | Â | <3 | 1.0 | 0.14 | |
  No | 1.0 | 0.74 | 3-6 | 0.61(0.3-1.02) |  |
  Yes | 0.74(0.17-3.50) |  | >6 | 0.91(0.53-1.55) |  |
Child score | 1.02(0.93-1.12) | 0.59 | Platelets counts (10 9 /L) | 1.01(1.0-1.01) | <0.001 |
Child class | Â | AFP(IU/ml) | Â | ||
  A | 1.0 | 0.50 | ≤200 | 1.0 | 0.53 |
  B | 1.02(0.50-2.11) |  | >200 | 0.86(0.56-1.34) |  |
  C | 1.32(0.65-2.67) |  | Duration between diagnosis of cirrhosis |  | |
Okuda class | Â | 00 | 2.90(1.43-5.88) | <0.001 | |
  I | 1.0 | 0.97 | 1-55 | 1.10(0.51-2.40) |  |
  II | 0.99(0.52-1.87) |  | >55 | 1.0 |  |
  III | 1.15(0.51-2.15) |  | Mode of diagnosis |  | |
Complication of CLD | Â | On screening | 1.0 | 0.001 | |
  No | 1.0 | 0.39 | Incidental | 15.36(1.93-122.14) |  |
  Yes | 1.24(0.74-2.07) |  | Symptomatic | 9.82(1.34-72.01) |  |
Hyperspleenism | Â | Stage of HCC | Â | ||
  No | 1.0 | 0.14 | Non-Advance | 1.0 | <0.001 |
  Yes | 0.72(0.46-1.11) |  | Advance | 3.08(1.79-5.28) |  |
Ascites | Â | Macroscopic types of HCC | Â | ||
  No | 1.0 | 0.84 | Solitary | 1.0 | 0.04 |
  Yes | 0.95(0.60-1.51) |  | Paucifocal (≤ 3 nodules) | 1.04(0.62-1.73) |  |
PSE | Â | Multifocal(>3 nodules) | 1.38(0.73-2.63) | Â | |
  No | 1.0 | 0.23 | Massive/infiltrative | 2.7(1.28-5.69) |  |
  Yes | 1.31(0.84-2.03) |  | Maximum tumor size(cm) |  | |
Esophageal Varices | Â | < 5 | 1.0 | <0.001 | |
  No | 1.0 |  | 5-10 | 2.08(1.39-3.75) |  |
  Yes | 0.84(0.55-1.29) | 0.44 | >10 | 5.46(3.01-9.93) |  |
Upper GI bleed | Â | Hepatic Lobes | Â | ||
  No | 1.0 |  | Left | 1.0 | 0.98 |
  Yes | 0.90(0.58-1.40) | 0.64 | Right | 1.05(0.53-2.06) |  |
Hepatohydrothorax | Â | Both | 1.03(0.49-2.16) | Â | |
  No | 1.0 | 0.43 | Porto Venous Thrombosis |  | |
  Yes | 1.32(0.66-2.65) |  | No | 1.0 | 0.33 |
Hepatorenal Syndrome | Â | Yes | 1.25(0.788-2.00) | Â | |
Extra hepatic spread | Â | ||||
  No | 1.0 | 0.50 | No | 1.0 | 0.12 |
  Yes | 1.18(0.72-1.94) |  | Yes | 1.58(0.89-2.81) |  |